Thiamine transporter-2 deficiency (THMD2, OMIM#607483), also called biotin thiamine responsive basal ganglia disease (BTBGD) was first described by Ozand et al. (1998). This evidence concerns the gene SLC19A3 and biotin-responsive basal ganglia disease.